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Osterix (Osx) is an osteoblast-speciﬁc transcription factor
required for osteoblast differentiation and bone formation.
Osx null mice develop a normal cartilage skeleton but fail
to form bone and to express osteoblast-speciﬁc marker
genes. To better understand the control of transcriptional
regulation by Osx, we identiﬁed Osx-interacting proteins
using proteomics approaches. Here, we report that a
Jumonji C (JmjC)-domain containing protein, called
NO66, directly interacts with Osx and inhibits Osx-
mediated promoter activation. The knockdown of NO66
in preosteoblast cells triggered accelerated osteoblast dif-
ferentiation and mineralization, and markedly stimulated
the expression of Osx target genes. A JmjC-dependent
histone demethylase activity was exhibited by NO66,
which was speciﬁc for both H3K4me and H3K36me
in vitro and in vivo, and this activity was needed for the
regulation of osteoblast-speciﬁc promoters. During BMP-2-
induced differentiation of preosteoblasts, decreased NO66
occupancy correlates with increased Osx occupancy at
Osx-target promoters. Our results indicate that interac-
tions between NO66 and Osx regulate Osx-target genes
in osteoblasts by modulating histone methylation states.
The EMBO Journal (2010) 29, 68–79. doi:10.1038/
emboj.2009.332; Published online 19 November 2009
Subject Categories: chromatin & transcription; differentiation
& death
Keywords: demethylase; Jumonji; NO66; osteoblast; Osterix
Introduction
Bone formation occurs through two distinct processes. Many
skeletal elements form by endochondral ossiﬁcation, which
involves a cartilage intermediate. The other skeletal ele-
ments, which mainly consist of craniofacial bones, are
formed by intramembranous ossiﬁcation, whereby bones
form directly from mesenchymal condensations (Fang
and Hall, 1997). Despite these differences, osteoblast differ-
entiation is controlled by an identical set of transcription
factors: Runx2, Osterix (Osx), and b-catenin that have essen-
tial roles in both processes (Ducy et al, 1997; Nakashima
et al, 2002; Hill et al, 2005; Komori, 2006; Rodda and
McMahon, 2006).
Runx2 is required at an early step and Osx is needed at a
later step of osteoblast differentiation. The Osx is speciﬁcally
expressed in osteoblast lineage cells and at lower levels in
prehypertrophic chondrocytes. The Osx contains a proline-
and serine-rich transactivation domain located in the N-
terminal part of the protein and three DNA-binding C2H2-
type zinc ﬁngers at its C-terminus. Osx-null mice, which die
at birth, have a normal cartilage skeleton, including the
development of normal hypertrophic cartilage, but comple-
tely lack bone formation. In all skeletal elements of Osx-null
embryos, precursor cells are arrested at their differentiation
and consequently fail to express osteoblast-speciﬁc marker
genes (Nakashima et al, 2002). Several factors, including
HDACs, Twist 1 and 2, ATF4, NFATc, Msx, and Dlx also
have important roles in the differentiation and function of
osteoblasts (Nakashima and de Crombrugghe, 2003; Hassan
et al, 2004; Vega et al, 2004; Yang and Karsenty, 2004; Koga
et al, 2005; Cheng et al, 2008).
In addition to the various classes of transcription factors,
the transcriptional control of gene expression also depends
on the state of histone modiﬁcations, which provides a
dynamic control of chromatin activity. Methylation of
H3K9, H3K27, or H4K20 is often associated with inactive
chromatin, whereas methylation of H3K4, H3K36, H3K79,
and H3R17 is largely associated with active gene transcrip-
tion (Strahl and Allis, 2000; Lachner and Jenuwein, 2002;
Martin and Zhang, 2005).
The identiﬁcation of histone lysine demethylases, includ-
ing lysine speciﬁc demethylase1 (LSD1) and jumonji (JmjC)-
domain containing proteins has provided strong evidence
that histone methylation is reversible and dynamically regu-
lated, much like histone acetylation and phosphorylation
(Shi et al, 2004; Klose et al, 2006). Several JmjC-domain-
containing histone demethylases (JHDMs) reverse methyla-
tion states at lysines 4, 9, 27, 36 and 79 of H3 and thus
regulate the activation of target genes in chromatin (Fodor
et al, 2006; Klose et al, 2006; Tsukada et al, 2006; Whetstine
et al, 2006; Yamane et al, 2006; Agger et al, 2007; De Santa
et al, 2007; Iwase et al, 2007; Lan et al, 2007; Lee et al,
2007).
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68In osteoblasts, histone acetylases and deacetylases
(HDACs) control the activity of Runx2 (Shen et al, 2002;
Schroeder et al, 2004; Kang et al, 2005). In addition, HDAC4
was shown to inhibit the differentiation of hypertrophic
chondrocytes by negatively regulating Runx2 activity (Vega
et al, 2004). Moreover, the histone lysine methytransferase
Wdr5 has been reported to be involved in osteoblast differ-
entiation (Zhu et al, 2008), but no histone demethylases have
been shown to regulate osteoblast-speciﬁc genes.
In a screen for polypeptides that associate with Osx, we
identiﬁed the JmjC domain-containing protein NO66. This
protein was previously described as a component of nucleoli
in Xenopus embryos that co-fractionated biochemically with
preribosomal particles (Eilbracht et al, 2004). The NO66 is
highly conserved in eukaryotes, and immunoﬂuorescence
studies revealed that the protein is present in both the
granular part of nucleoli and in the nucleoplasm of tissue
culture cells (Eilbracht et al, 2004). However, not much is
known about its function. Here we show that NO66, which is
present in all bones as observed on the basis of histochemical
studies, inhibits transcription of Osx-dependent promoters.
We present evidence that NO66 is a histone demethylase for
H3K4me and H3K36me, and that this activity is required for
the inhibition of the transcriptional activation by Osx.
Importantly, our experiments strongly support a physiologi-
cal role for NO66 during osteoblast differentiation.
Results
JmjC-domain containing protein NO66 is an
Osx-interacting protein
To deﬁne the regulation of Osx transactivation in osteoblast
differentiation, we stably transfected Flag–HA–Osx into the
mouse C2Cl2 line, which differentiates into osteoblasts on
BMP-2 addition. The induction of Flag–HA–Osx in this cell
line (referred to as C2-Osx) occurs after tetracycline
withdrawal. Using tandem afﬁnity puriﬁcation followed by
SDS–PAGE fractionation and mass spectrometry, we identi-
ﬁed Osx-interacting polypeptides in nuclear extracts of this
cell line. One of the proteins co-purifying with Flag–HA–Osx
was the Jumonji C (JmjC) domain-containing protein NO66
(Figure 1A).
The co-puriﬁcation of NO66 with Osx in lysates of C2-Osx
cells grown without tetracycline and with or without BMP-2
treatment was conﬁrmed by immunoprecipitation with a-Flag
antibody followed by western blot using a-NO66 antibody.
No NO66 was detected after immunoprecipitation of tetracy-
cline-treated C2-Osx cell lysates, conﬁrming that NO66 was
co-immunoprecipitated with Flag–HA–Osx, and that NO66
and Osx are part of a common complex (Figure 1B). In a
similar experiment, other co-puriﬁed proteins, such as
Yb-1 and Flightless, were also detected in a-Flag immuno-
precipitates, thus conﬁrming our mass spectrometry analysis
Figure 1 Identiﬁcation of NO66 as an Osx-interacting protein. (A) Polypeptides co-puriﬁed with Flag–HA–Osx by tandem immunoafﬁnity from
nuclear extracts of BMP-2-treated C2-Osx cells were separated on a 4–20% gradient SDS gel followed by silver staining. (B) Total cell lysates of
C2-Osx cells, grown as indicated above, from each lane were immunoprecipiated using a-Flag agarose followed by immunoblot with a-NO66
antibody (top panel). The blot was stripped and then probed with a-Flag antibody to detect Flag–HA–Osx immunoprecipitates (bottom panel).
Different exposure time was used for each antibody. The faint band in the input lane was from a diluted lysate sample. A longer exposure time
was used to detect input signal in bottom panel. (C) Co-immunoprecipitation of myc-NO66 and HA-Osx in lysates of co-transfected HEK293T
cells. Top panel—immunoprecipitation of Flag–HA–Osx with HA-tagged antibody followed by immunoblotting with myc-tagged antibody for
myc-NO66, Bottom panel—immunoprecipitation of myc-NO66 using anti-myc antibody followed by immunoblotting with HA-tagged antibody
for Flag–HA–Osx. Lane 1 in both cases represents 5% of the cell lysate used in lanes 2 and 3. (D) Interactions of endogenous NO66 and Osx in
rat osteosarcoma UMR 106 cells were analysed by immunoprecipitation of cell lysates with rabbit a-Osx followed by immunoblot with a-NO66.
Input lane represents 10% of the lysate used in other two lanes. (E) GST pulldown of puriﬁed Osx by puriﬁed GST-NO66. The complexes
retained by glutathione Sepharose beads were separated by SDS–PAGE and analysed by western blot with S-epitope antibody for Osx. Lane 3
represents 10% of the puriﬁed Osx used in lane 1 and 2. (F) GST pull down of labelled NO66 by recombinant GST–Osx (1–270). Input lane
represents 10% of lysate used in the two lanes.
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was also observed in HEK293Tcells co-transfected with Flag–
HA–Osx and myc–NO66 expression vectors (Figure 1C). Myc-
tagged NO66 was found in the a-HA immunoprecipitates of
whole cell lysates (Figure 1C, top panel), and Flag–HA–Osx
was present in a-myc immunoprecipitates (bottom panel).
In addition, co-immunoprecipitation of endogenous Osx
and endogenous NO66 was also observed in rat osteosarcoma
UMR 106 cells (Figure 1D), which are highly differentiated
osteoblasts, further indicating that NO66 is associated with
Osx in differentiated osteoblasts. Puriﬁed recombinant GST–
NO66 retained puriﬁed recombinant Osx in a pull-down assay
(Figure 1E) indicating that these two proteins interac-
ted directly with each other. Moreover, another pull-down
experiment showed that
35S-labelled NO66 interacted with a
segment of Osx (1–270) that contains the transactivation
domain but lacks the DNA-binding domain, indicating that
this Osx segment was sufﬁcient for NO66 interactions
(Figure 1F).
NO66 inhibits the transcriptional activation of Osx
Our previous studies showed that Osx is expressed in all
endochondral and membranous skeletal elements during
mouse embryonic development beginning at E13.5 and con-
tinuing after birth (Nakashima et al, 2002). In situ hybridiza-
tions using an anti-sense RNA probe showed that NO66 RNA
co-localized with Osx RNA starting at E14.5. The NO66 RNA
was present in all developing endochondral and membranous
bones, such as E15.5 vertebrae and mandible and E18.5
femur, tibia, and ﬁbula (Figure 2A). Immunohistochemistry
of skeletal tissue sections using an NO66-speciﬁc antibody
conﬁrmed the presence of NO66 in developing bones
Figure 2 NO66 is expressed in developing bone and inhibits Osx-target gene activation. (A) NO66 is expressed in all developing mouse skeletal
tissues as shown by in situ RNA hybridizations of NO66 in mouse vertebrae (V) and mandible (M) at E15.5, and ﬁbula (F), tibia (T), and femur
(Fe) at E18.5. H, hypertrophic cartilage; P, prehypertrophic cartilage. Expression of Osx is also shown in parallel sections of mouse vertebrae
(V) and mandible (M) at E15.5. (B) Immunohistochemistry to monitor NO66 protein expression in vertebrae (V) and tibia (T) at E14.5, and
ulna (U) at E15.5. (C) NO66 inhibits transcriptional activation by Osx. Stimulation of a 2-kb mouse Bsp promoter (left) and a 1.1-kb mouse
Osteocalcin promoter (middle) by increasing amounts of Osx (pTriEX Flag–HA–Osx) in HEK293Tcells and inhibition by co-expression of NO66.
Levels of Osx and NO66 in transfected cells were analysed by western blotting (below, left panel). The P-value (o0.05) for statistical difference
was calculated using one way ANOVA test and is indicated by asterisks. Quantitative PCR of Osteocalcin mRNA in BMP-2-treated C2C12 cells
transfected with a NO66 expression plasmid (right panel). The error bars represent s.e.m. values of at least triplicate experiments. (D) Western
blot of the knockdown of NO66 in lysates of BMP-2-treated C2C12 cells by a NO66-speciﬁc RNA. NsiRNA is non-speciﬁc siRNA. b-Actin serves
as loading control. (E) Increased expression of Osx target genes by knockdown of NO66. Representative quantitative RT–PCR of Osx, Col1a1,
and Osteocalcin (Oc) RNAs in C2C12 cells transfected with siRNAs and treated with BMP-2. (F) Same as (E), but for Bone sialoprotein (Bsp) and
Osx RNAs in MC3T3 cells. RNA levels were measured relative to those of mock-transfected cells that were also treated with BMP-2.
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cDNA probe also showed expression of NO66 in the human
Saos-2 and rat UMR106 ostesarcoma cell lines, as well as in
RNA preparations from human trabecular bone (Supple-
mentary Figure S2). Others have observed expression of
NO66 in several mouse tissues and cell lines (Eilbracht
et al, 2004). All together these studies indicate that NO66 is
widely, but not ubiquitously, expressed.
In Osx null embryos, expression of osteoblast-speciﬁc
marker genes such as Osteocalcin (Oc) and Bone sialoprotein
(Bsp) is completely lost, indicating that Osx is required for the
expression of these genes (Nakashima et al, 2002). To further
examine the effects of Osx on transcription of osteoblast-
speciﬁc promoters, we transfected HEK293Tcells with an Osx
expression vector. Osx strongly stimulated the 2-kb Bsp
promoter (Figure 2C, left panel) as well as the 1.1-kb
Osteocalcin promoter in a dose-dependent manner (middle
panel). Although the basal activity of these reporters showed
little change in the presence of NO66, co-expression of NO66
with Osx inhibited Osx-mediated activation of the reporters
by 70–80%. The overexpression of NO66 in these cells did
not affect the level of Osx (left, bottom panel). In control
experiments, NO66 also did not inhibit the activity of differ-
ent reporters driven by Sox9, ATF6, or GAL4-DBD-VP16
(Supplementary Figure S3A–C). These results indicate that
although NO66 markedly inhibited transcriptional activation
by Osx, it is not a general transcriptional inhibitor.
Previously we have shown that a proline-rich activation
domain spanning amino-acid residues 27–192 in Osx was
required for the activation of the 5XGAL4-Luc reporter
(Nakashima et al, 2002). Using GAL4-DBD-Osx (27–192)
and 5XGAL4-Luc in reporter assays, addition of either sodium
butyrate (inhibitor of class I and II HDACs) or nicotinamide
(inhibitor of class III HDACs) did not relieve the NO66-
mediated inhibition of Osx-dependent transactivation
(Supplementary Figure S3D). These data suggest that the
inhibitory effects of NO66 on Osx-dependent transcription
were not mediated by HDACs and that NO66 did not recruit
HDACs to repress Osx-mediated transactivation.
To verify that NO66 inhibits the expression of endogenous
osteoblast-speciﬁc genes, we measured expression of the
endogenous Osteocalcin (Oc) gene in BMP-2-induced osteo-
blasts that overexpressed NO66. The transfection of C2C12
cells with NO66 expression vector followed by BMP-2 treat-
ment for 24 and 48h decreased Oc mRNA by almost 50%
compared with mock-transfected cells after 48h of BMP-2
treatment (Figure 2C, right panel).
To complement the above experiments, we next ques-
tioned whether loss of NO66 expression would result in
increased expression of Osx-dependent genes in osteoblasts.
The C2C12 cells were ﬁrst either mock transfected or trans-
fected with control or NO66-speciﬁc siRNAs, followed by
treatment with BMP-2 to induce osteoblast differentiation.
Immunoblots of whole-cell lysates using an a-NO66 antibody
indicated that the NO66-speciﬁc siRNA, but not the control
siRNA (Nsi-non-speciﬁc), signiﬁcantly inhibited NO66 ex-
pression (Figure 2D). Strikingly, knockdown of NO66 by
siRNA increased the levels of Col1a1 and Oc RNAs compared
with those in control siRNA-transfected C2C12 cells
(Figure 2E). Similar experiments were performed in
pre-osteoblast mouse cell line, MC3T3-E1, which can also
differentiate into osteoblasts after BMP-2 treatment. The
transfection of NO66-speciﬁc siRNA followed by BMP-2
addition led to marked stimulation of Bsp expression, when
compared with control siRNA-transfected cells, which were
also treated with BMP-2 (Figure 2F). However, expression of
Osx was not affected by transfection of either NO66-speciﬁc
or control siRNAs in either cell line (Figure 2E and F). Thus,
knockdown of NO66 in osteoblasts caused increased expres-
sion of osteoblast-speciﬁc marker genes, suggesting an
important role for NO66 in the regulation of osteoblast
differentiation.
Knockdown of NO66 accelerates osteoblast
differentiation and maturation
To further test our hypothesis that NO66 has a physiological
role as a negative regulator of osteoblast differentiation and
maturation, we generated MC3T3 cell lines expressing stably
transfected NO66-speciﬁc and non-speciﬁc shRNAs. Levels of
NO66 were markedly decreased in NO66sh cells compared
with control Nsh cells (Figure 3A). Histochemical and quan-
titative analyses showed that the production of alkaline
phosphatase, an early marker of osteoblast differentiation,
was accelerated in NO66-shRNA-expressing cells (NO66sh)
compared with control Nsh cells, when these cells were
cultured in osteogenic medium for the indicated periods
(Figure 3B and C). Further, the extracellular matrix miner-
alization, a late event, as shown by alizarin red S staining was
also accelerated in NO66sh-treated cells compared with
control Nsh-treated cells (Figure 3D). These results suggest
that knockdown of NO66 in preosteoblast MC3T3 cells
caused these cells to differentiate earlier than control cells.
In addition, expression levels of the Osx-dependent Bsp
and Osteocalcin matrix forming genes were markedly stimu-
lated in NO66sh cells relative to in control cells (Figure 3E),
further indicating our interpretation that acceleration of
osteoblast differentiation in NO66-deﬁcient cells was due to
increased expression of these matrix genes. All together,
these data strongly indicate that knockdown of NO66
accelerates the rate of osteoblast differentiation and matura-
tion of MC3T3 cells.
NO66 has histone demethylase activity that is required
for inhibition of Osx-dependent activation
Given the existence of the JmjC domain in NO66, and the
presence of conserved amino acids that have been implicated
as co-factor-binding sites in several other JmjC-containing
proteins (Klose et al, 2006 and Figure 4A), we tested NO66 for
histone demethylase activity. Using calf thymus histones as
substrates, we found that recombinant NO66 very
efﬁciently demethylated H3K4me3 and H3K4me1, and to a
lesser extent H3K4me2 (Figure 4B). NO66 also demethylated
H3K36me3 and H3K36me2. In contrast, no activity was
observed towards H3K9me3 or H3K27me3 (Figure 4C, lanes
1–2 and 3–4, respectively). These results showed that NO66
is a histone demethylase speciﬁc for lysine 4 and 36 of
histone H3.
We next tested whether, as in other JHDMs, the potential
co-factor binding sites in the JmjC domain of NO66 were
essential for demethylase activity by comparing the activity
of wild-type NO66 with that of mutant NO66 protein
(see Supplementary Figure S4 for enzyme preparation). Our
results showed that a mutant protein bearing two histidine-
to-alanine substitutions in conserved sites critical for ferrous
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activity towards H3K4me3 or K36me3 (Figure 4C, lanes 3
and 4). This indicated that the mutations crippled the activity
of NO66. The omission of co-factor a-KG from the demethy-
lase reaction mixture inhibited the demethylase activity of
NO66 (Figure 4D, compare lane 2 and 4). In the absence of
added Fe
þþ ions the inhibition of NO66 activity was less
pronounced, maybe because intrinsic Fe
þþ ions remained
bound to our preparation of NO66 (compare lane 2 and 3).
However, addition of EDTA, which chelates Fe
þþ ions,
markedly inhibited the demethylase activity of NO66 for
H3K4me3 (compare lane 2 and 5). The level of H3K4me3 in
the presence of EDTA was similar to that present in control
reaction with no enzyme (lane 1 and 5). These data strongly
suggest that NO66 is a co-factor-dependent JmjC histone
demethylase and that co-factors Fe
þþ ions and a-KG are
needed for full enzymatic activity.
To determine whether NO66 has demethylase activity in
cultured cells, we overexpressed wild-type NO66 or a mutant
in COS7 cells and monitored histone methylation levels by
immunoﬂuorescence using site-speciﬁc antibodies. The over-
expression of wild-type NO66 clearly reduced the intensity of
H3K4me3 and to lesser extent H3K36me3 staining, but not
the intensity of H3K27me3 staining (Figure 4E). Similarly, the
intensity of anti-H3K4me2, K4me1 and K36me2 staining was
also reduced by overexpression of wild-type NO66 in COS7
cells (Supplementary Figure S5). In contrast, overexpression
of the NO66 (H339A/H404A) mutant, which was inactive in
the in vitro assay, did not reduce immunostaining of
H3K4me3 or H3K36me3 (Figure 4E). Thus, both in vitro
assays and in-cell assays indicate that NO66 exhibited
H3K4- and H3K36-speciﬁc demethylase activity.
To test whether the demethylase activity of NO66 was
required for the inhibition of transcriptional activation by
Osx, we examined the effect of NO66 demethylase mutants
on Osx-dependent reporter activation using 5XGAL4-Luc co-
transfected with Osx (27–192) and wild-type or mutant
NO66. In contrast to wild-type NO66, which exhibited de-
methylase activity for H3K4me3 and H3K36me3 (Figure 4)
and repressed Osx-mediated activation (Figure 4F and
Supplementary Figure S3D), NO66 mutants (H339A or
H339A/H404A) did not inhibit Osx-mediated transcriptional
activation (Figure 4F).
Domain of NO66 that interacts with the activation
domain of Osx
As described above, Figure 1F showed that the transcription
activation domain of Osx interacted with NO66. To further
Figure 3 Stable depletion of NO66 by shRNA accelerates osteoblast differentiation. (A) Immunoblot of NO66 in MC3T3 cell line stably
transfected with NO66-speciﬁc shRNA (NO66sh) compared with control cells stably transfected with non-speciﬁc shRNA (Nsh). b-Actin serves
as loading control. (B, C) Left, representative staining of alkaline phosphatase activity (ALP); right, quantiﬁcation of ALP, and (D)
representative staining of extracellular matrix deposition by 1.4% Alizarin S red in NO66sh and Nsh cells after culture for indicated times
in osteogenic medium. Post-staining, photograph was taken with computer-assisted scanning and images with equal area in each case are
shown. (E) Representative quantitative RT–PCR of Bsp and Oc RNAs after 10 days culture of these cells in osteogenic medium.
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domain of Osx, we performed an in vitro interaction assay
using recombinant polypeptides. Two NO66 mutants (M1 and
M2) were tested for their ability to physically interact with
GST–Osx (1–270) in pull-down assay (Figure 5A and B). The
NO66 mutant M1, which retained an intact JmjC domain and
the C-terminus of NO66, interacted with GST–Osx (1–270),
whereas the mutant M2, which had an internal deletion
including a part of the JmjC domain, did not interact with
GST–Osx (1–270), indicating that the segment between 168
and 386 containing the JmjC domain of NO66 was necessary
for strong interactions with the activation domain of Osx.
Next we examined the effect of full-length NO66 or M1 and
M2 mutants on the ability of a GAL4–Osx fusion polypeptide
(27–192) to activate a 5XGAL4-Luc reporter gene. This do-
main of Osx was shown previously to be necessary and
sufﬁcient for the activation of this reporter (Nakashima
et al, 2002). The co-transfection of GAL4–Osx (27–192)
with wild-type NO66 or mutant M1 resulted in dose-depen-
dent inhibition of 5XGAL4-Luc reporter activity, thereby
strongly suggesting that inhibition by NO66 was mediated
through the activation domain of Osx (27–192) (Figure 5C). It
should be noted that both polypeptides were able to interact
physically with Osx (Figures 1E and F, and 5B). In contrast,
the mutant M2, which did not interact with Osx owing to a
partial deletion of the JmjC domain, showed weak inhibition
of Osx-dependent activation even with the highest levels
tested.
To map the NO66-interacting segment present in Osx, we
used Osx deletion mutants together with NO66 mutant M1
in co-immunoprecipitation experiments (Figure 5D). These
results indicated that Osx C-terminal truncation mutants
(1–175 and 1–288) that lacked the zinc ﬁnger DNA-binding
domains co-immunoprecipitated with the NO66 M1 mutant,
suggesting that an Osx segment spanning amino acids 1–175
residues was sufﬁcient to interact with NO66. However, Osx
mutants bearing N-terminal deletions (89–428, 175–428, and
288–428) were not co-immunoprecipitated by the NO66
Figure 4 NO66 has H3K4me and H3K36me demethylase activity. (A) Comparison of conserved catalytic amino acids within JmjC domain of
NO66 and JHDM1A (* sites for Fe
þþ binding and
# for a-ketoglutarate binding). (B) NO66 histone demethylase activity was assayed with
recombinant NO66 puriﬁed from insect cells and calf thymus bulk histones (Sigma) followed by immunoblotting with site-speciﬁc methyl
antibodies. (C) The demethylase activity of NO66 mutant protein with double substitution mutations (H339A, H404A) was compared with the
activity of wild-type NO66 (Wt). The GST-tagged proteins were expressed and puriﬁed from Sf9 cells (see details in Supplementary Figure S3).
The demethylase activity was assayed by western blotting using speciﬁc antibodies as indicated in the panel. All lanes in this panel came from
the same gel. (D) Recombinant His-tagged NO66, afﬁnity puriﬁed from transfected HEK 293Tcells, was used for demethylase reaction assay in
the presence or absence of co-factors and EDTA (50mM) as indicated in the panel. Ascorbate was added to each reaction mixture. The
demethylase activity was assayed by western blotting. (E) Overexpression of wild-type NO66 in transfected COS7 cells decreased the intensity
of H3K4me3 and H3K36me3 (arrows) immunostaining, but not that of H3K27me3, whereas mutant NO66 (H339A, H404A) did not decrease
the intensity of H3K4me3 and H3K36me3. Both wild-type (WTand mutant NO66 were tagged with myc-epitope at their C-terminus and their
expression was detected with anti-myc antibody. (F) NO66 demethylase activity mediated the inhibition of the transcriptional activity of Osx.
DNA transfection experiments were performed in HEK 293T cells with WT NO66 and NO66 demethylase mutants (H339A, and H339 plus
H404A), as well as with GAL4–DBD–Osx (27–192) using the 5xGAL4-Luc reporter. Immunoblot shows expression levels of NO66 and mutant
proteins (inset).
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remove parts of the activation domain in Osx. These results
strongly indicate that an N-terminal segment of Osx that
includes the activation domain of Osx is required for inter-
actions with NO66.
Furthermore, we examined the effects of NO66 on the
ability of the Osx mutants (89–428 and 1–288) to transcrip-
tionally activate a Bsp-Luc reporter (Figure 5E). The Osx
(89–428) mutant was still able to stimulate Bsp-Luc reporter
activity, even though the activation domain is partially trun-
cated in this mutant, though the activation was less than that
observed with wild-type Osx (1–428). The co-transfection of
NO66 inhibited the activity of wild-type Osx in the reporter
assay, but NO66 was not able to inhibit the activity of the Osx
(89–428) mutant, consistent with the inability of this mutant
to interact with NO66. These results indicate that NO66
Figure 5 JmjC domain of NO66 interacts with the activation domain of Osx. (A) Schematic of NO66 and Osx and mutant forms of these
proteins used in this study. Conserved histidines within the catalytic JmjC domain are indicated by asterisk. (B) Left, recombinant His-tagged
NO66 mutants were afﬁnity puriﬁed from transfected HEK293Tcells and separated on 4–20% gradient SDS-gel followed by silver staining. Lane
2 and 3 represent 15% of proteins used in right panel. Lane 4 shows preparation of recombinant GST–Osx (1–270) in Escherichia coli, which
was analysed on a separate gel followed by Coomassie staining. Lane 1 refers to protein markers (M). Right, GST pull down of NO66 mutants
(M1 and M2) by puriﬁed GST–Osx (1–270) followed by western blot with myc-epitope antibody to detect mutant NO66. (C) JmjC domain of
NO66 was essential for inhibition of Osx activation, shown by reporter assays using 5xGAL4-Luc co-transfected with increasing amounts of WT
or mutant NO66 (50–200ng), and GAL4–DBD–Osx (27–192). Western blot showing level of expressed proteins in the lysates of transfected cells
(bottom). Asterisk indicates non-speciﬁc bands co-migrating with mutant M1 and M2. (D) The N-terminus segment of Osx interacts with
NO66. HEK 293T cells were transfected with Osx mutants as indicated in the panel together with NO66 mutant M1. Co-immunoprecitations
were performed in lysates of transfected cells using myc antibody followed by western blotting with HA antibody (left panel), and also with
myc antibody to detect the immunoprecipitates (right panel). (E) NO66 functionally interacts with N-terminus of Osx. Reporter assay was
carried out using Bsp-Luc co-transfected with WTand mutant Osx, and NO66 (top). Western blot showing level of expressed proteins in the
lysates of transfected cells (bottom).
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able to interact with and inhibit the activity of wild-type Osx
(1–428) but not mutant Osx (89–428). Another mutant Osx
(1–288), which contains an intact activation domain but
lacks a DNA-binding domain, was unable to stimulate repor-
ter activity, as expected, and NO66 did not further reduce the
activity of this mutant. Taken together, these data suggest that
under the conditions of our assay, functional interactions
between NO66 and Osx are required to inhibit Osx activation
of target genes.
Association of NO66 with the chromatin of Osx target
genes is inversely correlated with their activation in
osteoblasts
The addition of BMP-2 to MC3T3 preosteoblastic cells triggers
the sequential activation of osteoblast-speciﬁc genes resulting
in the differentiation of these cells into osteoblasts (Katagiri
et al, 1994; Nakashima et al, 2002; Figure 6A and B). Before
BMP-2 addition, the RNA levels of Osx, Bsp, and Oc were
either undetectable or very low. At 15h after BMP-2 addition,
the levels of Osx RNAwere already high but levels of Bsp and
Oc RNAs were still very low. At 30h after BMP-2 addition,
RNA levels of Osx, Bsp, and Oc were all high. In contrast,
cellular levels of NO66 protein levels showed little change
during BMP-2-induced differentiation, although some de-
crease in NO66 RNA level was observed at 30h after BMP-2
addition (Figure 6A and B).
To gain further insights into the physiological role of NO66
during osteoblast differentiation, we tested whether changes
occurred in the occupancy of Osx and NO66 at the promoters
of the Osx target genes Bsp and Oc. Chromatin immuno-
precipitations from MC3T3 cells after they were treated with
BMP-2 for 0, 15, and 30h (Figure 6C) indicated that NO66
occupancy at the two promoters was high before treatment,
whereas as expected, occupancy of Osx at these promoters
was negligible. After 15h, Osx occupancy had markedly
increased, whereas NO66 occupancy started to decrease at
the Bsp promoter, but interestingly, not yet at the Oc promo-
ter. At 30h after BMP-2 treatment, Osx occupancy continued
to increase whereas NO66 occupancy was markedly reduced.
The expression of Bsp and Oc genes was seen only after 30h
of BMP-2 addition, at a time when signiﬁcant depletion of
NO66 from promoters of these genes was observed. The
interactions of Osx or NO66 with the promoter of the
b-actin gene appeared to be within background levels, con-
ﬁrming the speciﬁcity of our ChIPs. Other experiments showed
that occupancy of Osx was much higher at the promoter of the
Oc gene than at the 30UTR region (Supplementary Figure S6),
which is consistent with other biochemical experiments,
indicating that the binding of Osx occurs at the promoter of
Oc gene and that mutations in the Osx-binding site results
in a loss of Osx-dependent promoter activity (Sinha et al,
unpublished observations). Thus, these results revealed a
marked correlation between decreased NO66 occupancy and
increased Osx occupancy at two Osx target promoters.
These observations suggest that Osx and NO66 may com-
pete for occupancy of target promoters. To test this idea, we
performed a reporter assay using the same osteoblast-speciﬁc
reporter (Bsp-Luc) used in the experiment described in
Figure 2C (left). In these transfection experiments, an amount
of NO66 plasmid (2X, Figure 6D) that was sufﬁcient to inhibit
Osx activation was used together with increasing amounts of
Osx (Figure 6D, also see Supplementary Figure S7 for titration
of NO66 dose required to inhibit Osx-dependent activation).
Our data showed that inhibition of the Osx-dependent activa-
tion by NO66 was overcome, at least in part, by increasing
amount of Osx (Figure 6D, left, bars 6–8). We also questioned
whether in these transfection experiments Osx affects the
occupancy of NO66 at the promoter of the reporter gene.
Hence, we performed ChIP experiments in cells co-trans-
fected with the reporter, NO66 and Osx. Our results showed
that interactions of NO66 with transfected Bsp promoter (Bsp-
luciferase), which occurred in the absence of Osx, were
decreased by 60–70% in the presence of Osx (Figure 6D,
right panel).
In independent experiments using BMP2-treated MC3T3
preosteoblasts, we also observed that levels of H3K4me3 and
H3K36me3 increased in parallel with the decrease in NO66
occupancy of the Bsp gene. Thus, depletion of NO66 at the
Bsp gene was associated with enhanced methylation of
histone H3 lysine residues that are linked with transcription-
ally active chromatin (Figure 6E). Furthermore, levels of H3
acetylation, RNA polymerase II and Wdr5 (a BMP2-inducible
histone lysine methyl transferase) increased at the promoter
of Bsp gene in BMP-2-treated MC3T3 cells, consistent with
active transcription of this gene (Supplementary Figure S8).
However, levels of H3K27me3, which is not a substrate for
NO66-mediated demethylation in vitro or in transfected cells,
were not changed by the addition of BMP-2 (Supplementary
Figure S9). In other control experiments, NO66 occupancy
was very low at the promoters of Osx (a BMP-inducible gene)
and Col2a1 genes, and was not changed by BMP-2 addition.
Col2a1 is a chondrocyte-speciﬁc marker gene and a target of
Sox9 activation; it remains transcriptionally inactive in os-
teoblast cells (data not shown). Taken together, our data
suggest that NO66 interactions speciﬁcally regulate two Osx
target genes, Bsp and Oc, and that expression of these genes
depends on chromatin remodelling activities that mediate
histone acetylation and methylation.
Interestingly, both Osx and NO66 seemed to occupy the
same region of Osx target promoters at 15h post BMP-2
addition (Figure 6C). To obtain additional evidence that Osx
and NO66 are able to occupy the same chromatin fragment,
we performed a re-ChIP experiment in C2-Osx cells. These
data conﬁrmed co-localization of Osx and NO66 in the same
segment of the Bsp promoter (Supplementary Figure S10),
suggesting the possibility that both proteins could be part of
the same chromatin bound complex, consistent with the
physical interactions we observed between NO66 and Osx
(Figure 1).
Discussion
Our experiments provide the ﬁrst evidence that transcrip-
tional activation by Osx can be regulated by the JmjC-domain
containing protein, NO66, which acts as a histone demethy-
lase. Given the essential function of Osx in activating a large
repertoire of genes in osteoblasts, our data strongly suggest
that NO66 has a major role in osteoblast differentiation and
function, adding a new layer of control in the regulation of
the genetic programme of osteoblasts. Our results further
emphasize the idea that chromatin remodelling is crucial for
the control of Osx function.
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&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 1 | 2010 75Figure 6 Association of NO66 with Osx target genes prevents their activation in osteoblasts. (A) Immunoblot analyses show the levels of Osx
and NO66 expression in lysates of MC3T3 cells at different times after BMP-2 addition. b-Actin served as loading control. (B) NO66, Osx, Bsp,
and Oc RNA levels in MC3T3 cells at different times after BMP-2 addition. As measured by quantitative RT–PCR. (C) Chromatin
immunoprecipitation (ChIP) experiments showing the relative binding of Osx (left) and NO66 (right) at promoters of the Bsp and Oc genes
in MC3T3 cells at different times after BMP-2 addition. Primers used correspond to region approximately  1.5kb upstream of the Bsp and at
 0.5kb upstream of the Oc gene. (D) Left, inhibition of Osx activation by NO66 depends on intracellular levels of Osx. Reporter assays using
Bsp-Luc in HEK 293Tcells after transfection with NO66 and increasing levels of Osx (1 ¼25ng). Right, ChIP assays were performed using
anti-His antibody for NO66 after transfection of HEK 293 cells as described in left panel (1 ¼250ng). (E) Representative ChIP experiments of
NO66 (left), H3K4me3 (middle), and H3K36me3 (right) occupancy at the Bsp gene before and after BMP2 treatment of MC3T3 cells for 40h.
A and B refer to two chromatin segments within the promoter ( 1.0kb, A) and the coding region (þ12kb, B) of the Bsp gene. Error bars
represent s.e.m. values of triplicate qPCR of representative ChIPassays. The data are presented as percent of input after subtracting control IgG
values. Levels of H3K4me3 and H3K36me3 were normalized with bound histone H3 after immunoprecipitation with histone H3 antibody.
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sient expression experiments required both physical interac-
tions between Osx and NO66, and the demethylase activity of
NO66. In these experiments the chromatinization of reporter
DNA templates should be less extensive than in the genome.
Moreover, although the inhibition of the transcriptional
activity of Osx might certainly be due to demethylation of
histone H3, it could possibly also be caused by demethylation
of proteins that form an active complex with Osx at the Bsp
and Oc promoters or even by demethylation of Osx itself.
Previous experiments by others have shown that LSD1
demethylates K370me2 in p53 to regulate its activity
(Huang et al, 2007). As NO66 does not affect the activation
of several other promoters by speciﬁc activators, the
inhibition of Osx activity by NO66 in transient transfection
experiments was highly speciﬁc, which we attribute to direct
interaction between Osx and NO66.
A physiological role for NO66 during osteoblast differen-
tiation is strongly supported by the acceleration of differen-
tiation and the marked increase in expression of osteoblast
marker genes during the spontaneous differentiation of MC3T3
preosteoblasts stably transfected with a NO66-shRNA. One
possible reason among others for the premature increase in
alkaline phosphatase in MC3T3 cells containing a NO66-spe-
ciﬁc shRNA would be that NO66 regulates the activity of other
factors needed for upregulation of early markers in osteoblasts,
a hypothesis that needs to be tested. In this context, it is
important to note that ectopically expressed Osx in bone
marrow stromal cells (BMSC) increased expression and activity
of alkaline phosphatase (Tu et al,2 0 0 6 ) .
During osteoblast differentiation both in intact mouse
embryos and after BMP-2 addition to preosteoblasts in cul-
ture, there is a sequential activation of osteoblast marker
genes starting with Runx2 and Osx and continuing later with
Osx target genes (Nakashima et al, 2002). Despite the con-
stant cellular levels of NO66 after BMP-2 addition to MC3T3
cells, the occupancy of NO66 at the endogenous Bsp and Oc
promoters decreased. In contrast, occupancy of Osx, acetyla-
tion of histone H3, Wdr5, and Pol II at these promoters
increased, consistent with active transcription of these
genes during osteoblast differentiation. Our data further
suggest that the hypothesis that depletion of NO66 from
these genes could be due to recruitment of Osx and chromatin
modifying enzymes involving histone or factor acetylation
and methylation, thus altering the chromatin from a
repressed to an active state, although, the exact mechanism
by which this occurs is not known.
The conserved histidine and lysine residues that are
needed for co-factor binding in other JHDMs are also present
in NO66. As substitution mutations in these conserved re-
sidues abrogated the demethylation activity of NO66 and
because NO66 was unable to demethylate H3K4me3 in the
absence of co-factors, we conclude that, like other JHDMs,
NO66 is a co-factor-dependent JmjC histone demethylase.
Several other known demethylases, including JMJD2A/2B/
2C (KDM4A/4B/4C) and yeast Rph1 possess dual substrate
speciﬁcity for both H3K9me and H3K36me; LSD1 (KDM1)
has substrate speciﬁcity for both H3K4me and H3K9me (Allis
et al, 2007). Interestingly, the dual substrate speciﬁcity we
observe for NO66 for H3K4me and H3K36me is so far unique
in that it targets these two markers of transcriptionally active
chromatin.
The NO66 belongs to the ‘JmjC-domain only’ subfamily
and lacks other functional motifs that are present in other
JHDMs, including PHD, tudor, bromo, C5HC2- and CXXC-
zinc ﬁnger, FBOX, Bright/Arid, or TPR domains. These motifs
are thought to mediate interactions between JmjC-containing
proteins and histones or other proteins (Klose et al, 2006).
Additional studies will need to delineate domains in NO66
that mediate such interactions.
In summary, our results provide, to the best of knowledge,
the ﬁrst evidence that a speciﬁc JmjC family histone
demethylase, NO66, controls the activity of a ‘master’
transcription factor that is essential for osteoblast differentia-
tion and bone development. Loss- and gain-of-function ex-
periments of NO66 in osteoblasts of mice should elucidate in
greater detail the physiological role of NO66 during embryo-
nic development and post-natally.
Materials and methods
Generation of cell lines stably transfected with an inducible
Osx expression vector
Mouse C2C12 cells were stably transfected with pTet-off (Clontech)
and selected on neomycin (G418). The G418 selected clones from
each cell line were then stably transfected with pTRE-Flag–HA–Osx
and pTK-hyg plasmids. Individual colonies were selected on both
G418 and hygromycin, expanded and maintained in the presence of
tetracycline (Tet). We veriﬁed that in several of these clones, Flag–
HA–Osx was not expressed in the presence of Tet and was highly
expressed in the absence of Tet, and furthermore, that these clones
expressed osteoblast-speciﬁc genes after BMP-2 treatment similarly
to the parental unstransfected cells (data not shown), indicating
that these clones had maintained their potential to differentiate into
osteoblasts. These clones were called C2-Osx and used for further
experiments.
Puriﬁcation and identiﬁcation of NO66 as an Osx-interacting
protein
C2-Osx cells were grown in the absence or presence of tetracycline
and treated with BMP-2 (300ng/ml) in DMEM containing 5%
bovine serum albumin. Cells grown in the presence of tetracycline
and BMP-2 served as control. Nuclear extracts were diluted in
buffer A (50mM Tris–Cl (pH 8), 150mM NaCl, 0.5% NP-40, 1mM
PMSFand protease inhibitor cocktail) and immunoprecipitated with
a-Flag antibody M2 agarose (Sigma) at 41C followed by elution with
3  FLAG peptide (200mg/ml) in buffer A. Eluted samples were
further immunoprecipitated with a-HA antibody agarose (Roche) at
301C followed by elution with HA peptide (1mg/ml) in buffer A,
precipitation with cold acetone, and separation on a 4–15%
gradient SDS–PAGE and Coomassie blue staining. Individual
polypeptides were eluted from the gel and analysed by mass
spectrometry.
Immunoprecipitation and western blot
Cells were washed with ice-cold phosphate-buffered saline (PBS)
and lysed in buffer B (containing 50mM Tris–Cl (pH 8), 150mM
NaCl, 1% NP-40) along with protease inhibitor cocktail. Total cell
lysates were incubated with primary antibody for 2–3h followed by
protein A/G-Sepharose (Amersham Bioscience) for one additional
hour at 41C. Beads were extensively washed twice with buffer B
then three times with buffer C (buffer B with 0.2% NP-40), boiled in
2  SDS sample buffer, separated on SDS–PAGE, transferred to a
nitrocellulose membrane and immunoblotted. Bound antibody was
detected by Super Signal chemiluminescence reagent (Pierce).
GST pull down assay
Puriﬁed GSTand GST–Osx (1–270) were incubated with
35S-labelled
NO66 for 1h at 41C, washed with buffer C containing 1mM PMSF
and protease inhibitor cocktail and the complexes pulled down by
glutathione Sepharose beads followed by SDS–PAGE.
35S-NO66 was
prepared with the TNT T7 Quick coupled system (Promega). In the
reciprocal experiment, puriﬁed GST and GST–NO66 bound to
glutathione resins were mixed with puriﬁed His-S-tagged Osterix
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41C for 2h. After washing, resins were boiled in the presence of SDS
sample buffer and polypeptides were separated on SDS–PAGE
followed by western blotting using a-S-tagged antibody to detect
Osterix.
Reporter assays, siRNA and shRNA transfections, and gene
expression
For all reporter assays, HEK293T cells were grown in DMEM,
transfected with 200ng of reporter construct, 50–200ng of expres-
sion vector, and 20ng of pSV40/LacZ to control for transfection
efﬁciency. Lysates were assayed for luciferase and b-galactosidase.
The C2C12 and MC3T3 cells were transfected with 100nM
stealth siRNAs (Invitrogen, USA) using lipofectamine 2000
(Invitrogen) for 48h and then treated with BMP-2 for 24h. For
quantitative gene expression, total RNA was isolated using
RNAeasy-Mini kit (Qiagen, Valencia, CA) and reverse-transcribed
with random hexamer primers (Archive cDNA synthesis kit,
Applied Biosystems). Complimentary DNA was used in triplicate
for real-time PCR analysis using Taqman primer-probe. Representa-
tive qRT–PCR of two independent experiments is shown for which
qPCR triplicate assays were performed. The experimental error of
triplicate PCR assay is shown by error bar. Levels of RNA were
normalized to those of GAPDH. Gene-speciﬁc primer-probes were
obtained from Applied Biosystems. Sequences of siRNA are
available on request.
Demethylation and immunoﬂuorescence
Recombinant NO66 or mutant protein, which were afﬁnity puriﬁed,
was incubated with 5mg calf thymus bulk histones (Sigma) in 50ml
demethylase buffer (20mM Tris–HCl (pH 7.5), 150mM NaCl, 50mM
(NH4)2 Fe(SO4)2  6(H2O), 1mM m-ketoglutarate, and 2mM
ascorbate). Reactions were carried out at 371C for 3–7h, terminated
by addition of 2  SDS-loading buffer, followed by separation on
SDS–PAGE and immunoblotted with appropriate antibodies
(a-H3K4me3, ab8580; a-H3K36me3, ab9050; a-H3, ab1791 from
Abcam and a-H3K27me3, 07–449 from Millipore).
COS7 cells were seeded on top of coverslip in 24-well plate and
transfected with 200ng expression plasmids for 36h. Cells were
washed with PBS, ﬁxed with 4% paraformaldehyde, permeabilized
with 1% Triton X-100, and blocked with 10% BSA. The cover slips
were incubated for 2h at room temperature with a-myc antibody
(9E10, Santa Cruz Biotechnology) and a-H3K4me3, washed and then
incubated with secondary antibody (goat-a-rabbit Alexa 594 and goat-
a-mouse Alexa 488, Molecular probes) for 1h at room temperature.
Cover slips were washed, mounted with antifade-Gold with DAPI
(Molecular Probes), and analysed by ﬂuorescence microscopy.
Knockdown of NO66 by shRNA and in vitro osteoblast
differentiation assay
Pre-osteoblast MC3T3 cells were stably transfected with control
non-speciﬁc and NO66 speciﬁc shRNAs (Open Biosystem, USA)
using Arrest-in transfection reagent and selected on puromycin
(2mg/ml) for 10 days. Puromycin resistant cells were pooled and
expanded in growth medium. Whole-cell lysates were used to
analyse the levels of NO66 in both cell lines by immunoblotting
with a-NO66 antibody. NO66-speciﬁc shRNA-expressing cells
(NO66sh) and control non-speciﬁc shRNA-expressing cells (Nsh)
were grown to conﬂuency and maintained in differentiating
medium (a-MEM with 7mM b-glycerol-phosphate and 50mg/ml
ascorbic acid for several days). Cells were stained for alkaline
phosphatase production using kit 86R (Sigma). Quantiﬁcation of
alkaline phosphatase activity was performed using Amplite colori-
metric alkaline phosphatase assay kit (ABD Bioquest, USA) as per
manufacturer’s instructions. For extracellular mineralization, cells
were stained with 1.4% Alizarin S Red (pH 4.2) for 10min. Post-
staining, plates were photographed by computer-assisted scanner. A
subset of these cells during their differentiation was used for
quantitative gene expression. Total RNA isolation, reverse-tran-
scription and quantitative PCR were performed as described above.
Construction of NO66 and mutant expression plasmids
Expression vector pcDNA-NO66, which contains a full-length
human NO66 with a myc-epitope at the N-terminus, was kindly
provided by M Schmidt-Zachmann (Eilbracht et al, 2004). This
plasmid was further modiﬁed to clone full-length NO66 cDNA
(1–1923bp) into EcoRI and XhoI sites of pcDNA3.1-myc to generate
NO66 protein with myc and His tag at the C-terminus. Construction
of NO66 mutants used conventional methods to clone into
pcDNA3.1-myc whereas those for Osx mutants were described
earlier (Zhang et al, 2008).
Expression and puriﬁcation of recombinant proteins
Human NO66 cDNAwas cloned into HT-FastBac vector (Invitrogen)
to add a His tag at N-terminus and GST-FastBac vector to generate
GST tag at N-terminus. The resulting construct was used to produce
baculovirus and then infected to Sf9 cells. The recombinant NO66
was expressed in Sf9 cells and puriﬁed using Ni
2þ–NTA agarose
(Qiagen) or glutathione-Sepharose 4B resin according to the
manufacturer’s protocol. His-S-tagged Osterix was cloned into
pBACgus-2cp transfer plasmid (Novagen), which was then used to
produce baculovirus.
Human NO66 cDNA and mouse Osx cDNA encoding amino-acids
1–270 were inserted into pGEX4T-1 and pGEX4T-2 (GE Healthcare),
respectively. The GST fusion polypeptides were expressed in
Escherichia coli (BL21, codonþ) and puriﬁed using glutathione-
Sepharose 4B resin (GE Healthcare) according to the manufacturer’s
protocol.
Chromatin immunoprecipitation and quantitative PCR
Sub-conﬂuent cells were treated with or without BMP-2 for different
time. The ChIP experiment was performed as described by
Kouskouti et al (2004), with some modiﬁcations. Approximately
1.75 10
7 cells were treated with 1% formaldehyde in serum-free
medium for 20min followed by a treatment with 125mM glycine.
Cells were washed with cold PBS, re-suspended in 10 volumes of
cell lysis buffer (25mM HEPES (pH 7.9), 1.5mM MgCl2, 10mM KCl,
0.1% NP-40, 1mM DTT, 0.5mM PMSF, and protease inhibitor
cocktail) and homogenized to release the nuclei that were then
lysed with nuclear lysis buffer (50mM HEPES (pH 7.9), 140mM
NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1%
SDS, 0.5mM PMSF, and protease inhibitor cocktail). Nuclear
extracts were sonicated and cleared by centrifugation. Sonicated
chromatin was diluted in lysis buffer without SDS to bring the ﬁnal
concentration of SDS to 0.05%. The antibodies speciﬁc to Osx,
NO66, and rabbit IgG for control were ﬁrst conjugated to magnetic
coated protein G beads (Magnetic Dyna beads-Protein G, Invitro-
gen, CA), which were previously blocked with 0.5% BSA in PBS.
After overnight immunoprecipitation at 41C with rotation, immu-
noprecipitated complexes were collected using a magnetic stand.
Washing, reversal of cross-links, and puriﬁcation of DNA from
immunocomplexes were done using EZ-ChIP kit (Millipore) as per
manufacturer’s instructions. For sequential ChIP experiments,
chromatins prepared from C2-Osx cells were immunoprecipitated
by HA–epitope antibody (ab9110, Abcam) and control IgG
antibodies. Flag–HA–Osx-bound chromatin fragments were re-
leased from a-HA antibody with HA peptides (1mg/ml, Roche
Diagnostics, USA), which speciﬁcally eluted Flag–HA–Osx-bound
chromatin, and then further re-immunoprecipitated with a-NO66
antibody in the presence of 50mg/ml yeast tRNA and 5mg/ml BSA.
All other conditions were essentially same as described above.
Quantitative PCR reactions were performed with 500nM of
primers, 5mlo f2   SYBR green I PCR master mix (Applied
Biosystems), 2ml DNA in a total 10ml reaction volume. Results were
computed as percent antibody bound per input and data were
shown after subtracting control IgG values. Representative ChIP
assays of at least three independent experiments are shown for
which qPCR triplicate assays were performed. The experimental
error of triplicate PCR assay is shown by error bar. Primers used for
qPCR were tested ﬁrst with input DNA to analyse a linear range of
ampliﬁcation. Primer sequences are available on the request.
Generation of polyclonal rabbit anti-NO66 antibody
Rabbit a-NO66 antibody was generated against the peptide epitope
(SYPEFVRVGDLPCDSVED), which is conserved at the C-terminus in
mouse, rat, and human NO66 protein, and antiserum was afﬁnity-
puriﬁed on peptide-conjugated matrices (service provided by Open
Biosystems, Huntsville, AL).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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